In July 2009, the family of Massachusetts teenager Yarushka Rivera went to their local Walgreens to pick up Topamax, an anti-seizure drug that had been keeping her epilepsy in check for years. Rivera had insurance coverage through MassHealth, the state's Medicaid insurance program for low-income children, and never ran into obstacles obtaining this life-saving medication.
A bipartisan group of senators is unveiling a draft measure to crack down on surprise medical bills, which they say have plagued patients with massive unexpected charges for care.
A new analysis finds the price of certain drugs varies widely depending on what city they are sold in.
Patient: Anne Soloviev, 76, of Washington, D.C.
The bill: $1,496.09 for Kerydin, a topical medication that treats toenail fungus. Originally produced by Anacor Pharmacueticals, the drug is now a product of Sandoz, a division of Novartis.